Synvista Therapeutics, Inc. is a biotechnology company, which engages in the development of diagnostic tests and pharmaceutical drugs for the treatment of diabetes. The company was founded in October 1986 and is headquartered in Parsippany, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SYNI is 0.000100 USD — it hasn't changed in the past 24 hours. Watch SYNVISTA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange SYNVISTA THERAPEUTICS INC stocks are traded under the ticker SYNI.
SYNI stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in SYNVISTA THERAPEUTICS INC price.
SYNI reached its all-time high on Jan 9, 1992 with the price of 1,912.500000 USD, and its all-time low was 0.000001 USD and was reached on Dec 21, 2016. View more price dynamics on SYNI chart. See other stocks reaching their highest and lowest prices.
SYNI stock is 0.00% volatile and has beta coefficient of −20.20. Track SYNVISTA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is SYNVISTA THERAPEUTICS INC there?
SYNVISTA THERAPEUTICS INC is going to release the next earnings report on Nov 18, 2024. Keep track of upcoming events with our Earnings Calendar.
No, SYNI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SYNI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNVISTA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNVISTA THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNVISTA THERAPEUTICS INC stock shows the sell signal. See more of SYNVISTA THERAPEUTICS INC technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.